Replies to post #22887 on Revive Therapeutics Ltd (RVVTF)

[Classic Warrior]

Classic Warrior ponders if CRBP was fast tracked by the FDA to Phase 3? If you believe in Bucillamine, stay vested. The warrior was expecting the drop, so it was not hard to accept. There was no pain or headaches from the drop in pps. Gaining all that cash for a $.04 drop is a yawn. $RVVTF will prevail. It does appear that the speed of the enrollment was quite slow. A trial in Asia would have been finished by now, results would have been interpreted and the warrior would be retired. Anyway, we wait with a little more cash in our pockets to finish the trials.

ps. The warrior is still hoping for EUA after the first 210.

pps. Pennys- Come on Man! Seriously?

ppps. The riddle remains: Why sell shares if greatness is around the corner? Results may be pushed back a few, but MF owes his shareholders an update by 2/1/21. Maybe the psychedelic growth, ventures, and partnerships are going to be more costly than previously thought? Who knows? So much goes on behind the scenes that we just simply don't have the information. Trust MF or not, this guy is all in. Peace. By Tuesday, we are back to $.46. Let's go!!!!

[Smoothie 1]

Duly noted.

[ragstorum]

Helps me to separate offering from clinical trial.

medicinecat good point about companies raising regardless of anticipated outcome of clinical trial. In case of CRBP they probably saw writing on the wall - their drug just wasn't that effective vs placebo.

Folks supportive of Revive's offering may see that the time value of cash now could outweigh value of waiting for a higher price offering later.

[RioDad]

Medicine did the other ticker you mention have the same buffer time fram as Revives?
There’s about 2 weeks with Revive.